Osteoporosis and lifestyle medicine

Arjun Bharat Mahadik; Ashok Bhimrao Giri; Akshay Sonaji Bhambre; Swapnil Ashok Mundhe; Ramdas D. Shinde

doi:10.30574/gscbps.2021.14.2.0054

Authors

Arjun Bharat Mahadik Pharmacy Practice Department, Shivlingeshwar College of Pharmacy, Almala Dist. Latur (MH), India.
Ashok Bhimrao Giri Pharmacy Practice Department, Shivlingeshwar College of Pharmacy, Almala Dist. Latur (MH), India.
Akshay Sonaji Bhambre Pharmacy Practice Department, Shivlingeshwar College of Pharmacy, Almala Dist. Latur (MH), India.
Swapnil Ashok Mundhe Pharmacy Practice Department, Shivlingeshwar College of Pharmacy, Almala Dist. Latur (MH), India.
Ramdas D. Shinde Pharmacy Practice Department, Shivlingeshwar College of Pharmacy, Almala Dist. Latur (MH), India.

DOI:

https://doi.org/10.30574/gscbps.2021.14.2.0054

Keywords:

Osteoporosis, Lifestyle medicine, Calcium, Vitamin D

Abstract

Osteoporosis is a major public health threat in this 21^st century. It has high prevalence among postmenopausal women & elder patients (age > 60 years). It is a skeletal disorder characterized by compromised bone strength and suffer having greater chances of fractures. Osteoporosis is a condition where bones became weak & brittle that may increase chances of fracture in the patients. According to the WHO criteria, osteoporosis is defined as a bone mineral density (BMD) that lies 2.5 standard deviations or more below the average value for young healthy women (a T-score of <-2.5 SD).

Osteoporosis is occurs due to too much bone mineral density is decreased that results into the changes in the structure of bone. Etiological factors includes advanced age, sex (women > male), sedentary lifestyle, minimal/ absence of sun exposure, smoking, alcohol consumption, hormonal imbalance and disease conditions such as diabetes, malignancies (multiple myeloma, lymphoma, leukemia).

The diagnosis of condition must be confirmed by using spine dual energy X- ray absorptiometry (DXA) with WHO T-score thresholds. Osteopenia or low bone mass is having T-score of –1 to -2.4 & on the basis of T score, it will be classified in to two types that is primary and secondary osteoporosis. Primary osteoporosis more common in disease such as postmenopausal osteoporosis (type1) and senile osteoporosis (type2).

It has severe morbid consequences, the prevention and management of this condition and associated fractures is considered to the essential to the maintenance of health status or quality of life (QoL) of patient. Patient can prevent to suffer from this condition by applying various tools of lifestyle medicines i.e. staying physically active or doing weight bearing exercises. Smoking cessation, moderate alcohol consumption are also became major approaches to manage or prevent occurrence of condition. Nutritious diet rich in calcium, vitamin D, Vitamin A, Vitamin C and other nutrition also play a key role in the management or prevention of disease.

Metrics

Metrics Loading ...

References

Vijay Samuel Raj V. “Osteoporosis: Physiotherapy Role in Management and Prevention.” Int J Physiother. 2016; 3(3).

(National Osteoporosis Foundation, USA, 2019)

Sozen T, Ozisik L, Calik Basaran N. An overview and management of osteoporosis. Eur J Rheumatol. 2017; 4(1): 46–56.

Conference C. Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement. 2000; 17(1): 1–45.

Organization WH. Who Scientific Group on the Assessment of Osteoporosis At Primary Health. World Heal Meet Rep Brussels, Belgium, 2004 [Internet]. 2007; (May 2004): 1–13.

Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, et al. American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol. 2017; 69(8): 1521–37.

Nuti R, Brandi ML, Checchia G, Di Munno O, Dominguez L, Falaschi P, et al. Guidelines for the management of osteoporosis and fragility fractures. Intern Emerg Med [Internet]. 2019; 14(1): 85–102.

Schwellnus MP, Patel DN, Nossel C, Dreyer M, Whitesman S, Micklesfield L, et al. Healthy lifestyle interventions in general practice Part 13: Lifestyle and osteoporosis. South African Fam Pract. 2011; 53(1): 31–9.

Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK, et al. Osteoporosis: A review of treatment options. P T. 2018; 43(2): 92–104.

Services USD of A and USD of H and H. Dietary Guidelines for Americans, 2020-2025. 9th Edition. Am J Clin Nutr. 2020; 34(1): 121–3.

Lambert C, Beck BR, Harding AT, Watson SL, Weeks BK. A protocol for a randomised controlled trial of the bone response to impact loading or resistance training in young women with lower than average bone mass: The OPTIMA-Ex trial. BMJ Open. 2017; 7(9): 1–12.

Vuolo L, Barrea L, Savanelli MC, Savastano S, Rubino M, Scarano E, et al. Nutrition and Osteoporosis: Preliminary data of Campania Region of European PERsonalised ICT Supported Service for Independent Living and Active Ageing. Transl Med @ UniSa [Internet]. 2015; 13(3): 13–8.

Mosekilde L. Osteoporosis and exercise. Bone. 1995; 17(3): 193–5.

Kling JM, Clarke BL, Sandhu NP. Osteoporosis prevention, screening, and treatment: A review. J Women’s Heal. 2014; 23(7): 563–72.

Ma CC, The M, Unit R, Infirmary BR, Bs B. epidemiological perspective: 1989; 82(December): 753–7.

Barrett-Connor E, Siris ES, Wehren LE, Miller PD, Abbott TA, Berger ML, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res. 2005; 20(2): 185–94.

Akkawi I, Zmerly H. Osteoporosis: Current concepts. Joints. 2018; 6(2): 122–7.

Geyer C. Postmenopausal osteoporosis: The role of lifestyle in maintaining bone mass and reducing fracture risk. Am J Lifestyle Med. 2017; 11(2): 125–8.

Doering, PL; Kennedy, WK; Boothby L. Substance-Related Disorders: Alcohol, Nicotine, and Caffeine. Pharmacotherapy - A Patophysiosiologic Approach (7th Edition) - Dipiro, JP; Talbert, RL; Yee, GC; Matzke, GR; Wells, BG; Posey, LM. 2008. 1083–1097.

Sports A, Basics M. ACSM Sports Medicine Basics Strength , Power and the Baby Boomer. US Department of Health and Human Services. Bone health and osteoporosis: a report of the Surgeon General. US Heal Hum Serv [Internet]. 2004; 437.

Allen S, Homan M, Kearns A, Kramlinger A. Diagnosis and Treatment of Osteoporosis How to Cite this Document Health Care Guideline. 2017; (July).

Chen LR, Ko NY, Chen KH. Medical treatment for osteoporosis: From molecular to clinical opinions. Int J Mol Sci. 2019; 20(9): 1–21.

Berg KM, Kunins HV, Jackson JL, Nahvi S, Chaudhry A, Harris KA, et al. Association Between Alcohol Consumption and Both Osteoporotic Fracture and Bone Density. Am J Med. 2008; 121(5): 406–18.

Casentini C, Chiaramonti G, Amedei A, Cioppi F, Falchetti A, Masi L, et al. The bone care nurse project. Clin Cases Miner Bone Metab. 2011; 8(1): 63–635.

Bartoszynski T, Shelah S. A note on small sets of reals. Vol. 356, Comptes Rendus Mathematique. 2018; 1053–1061 p.

Harding AT, Weeks BK, Watson SL, Beck BR. The LIFTMOR-M (Lifting Intervention for Training Muscle and Osteoporosis Rehabilitation for Men) trial: Protocol for a semirandomised controlled trial of supervised targeted exercise to reduce risk of osteoporotic fracture in older men with low bone mass. BMJ Open. 2017; 7(6).

Titchenal CA, Dobbs J. A system to assess the quality of food sources of calcium. J Food Compos Anal. 2007; 20(8): 717–24.

Raras NS, Suwondo A, Wahyuni S, Laska Y. 4th Asian Academic Society International Conference ( AASIC ).HEA-OR-106 4th Asian Academic Society International Conference ( AASIC ) 2016 Research design. 2016; (May): 332–8.

Penido MGMG, Alon US. Phosphate homeostasis and its role in bone health. Pediatr Nephrol. 2012; 27(11): 2039–48.

Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10): 2359–81.

Costello RB, Elin RJ, Rosanoff A, Wallace TC, Guerrero-Romero F, Hruby A, et al. Perspective: The case for an evidence-based reference interval for serum magnesium: The time has come. Adv Nutr. 2016; 7(6): 977–93.

Turck D, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Kearney J, Knutsen HK, et al. Dietary reference values for sodium. EFSA J. 2019; 17(9).

Weaver CM. Potassium and health. Adv Nutr. 2013; 4(3).

Lee YJ, Lee M, Wi YM, Cho S, Kim SR. Potassium intake, skeletal muscle mass, and effect modification by sex: Data from the 2008-2011 KNHANES. Nutr J. 2020; 19(1): 1–9.

Ha J, Kim SA, Lim K, Shin S. The association of potassium intake with bone mineral density and the prevalence of osteoporosis among older Korean adults. Nutr Res Pract. 2020; 14(1): 55–61.

Law MR, Wald NJ, Meade TW. Strategies for prevention of osteoporosis and hip fracture. Br Med J. 1991; 303(6800): 453–9.

Guadalupe-Grau A, Fuentes T, Guerra B, Calbet JAL. Exercise and bone mass in adults. Vol. 39, Sports Medicine. 2009; 439–468.

Kohrt WM, Bloomfield SA, Little KD, Nelson ME, Yingling VR. Physical activity and bone health. Med Sci Sports Exerc. 2004; 36(11): 1985–96.